Armando Orlandi: Italian excellence leading global cancer research
Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, shared a post on LinkedIn about a paper by Matteo Lambertini et al. published in Journal of Clinical Oncology:
“Groundbreaking research alert.
Proud to highlight the remarkable work led by Italian oncologist Prof Matteo Lambertini just published in Journal of Clinical Oncology!
This landmark international study of 4,752 young women with BRCA mutations delivers crucial evidence:
Women who knew their BRCA status before diagnosis:
- Had significantly smaller tumors (T1: 61.3% vs 32.4%)
- Showed less nodal involvement (65.9% vs 50.8%)
- Required less aggressive treatments
- Demonstrated better overall survival (HR: 0.61)
Key takeaway: Pre-diagnostic genetic knowledge saves lives through earlier detection and intervention.
As the largest global cohort study of young BRCA carriers (78 centers worldwide), this Italian-led research should reshape our approach to genetic testing in high-risk populations.
Congratulations to Prof Lambertini and team for this practice-changing contribution to precision oncology! Italian excellence leading global cancer research!”
Authors: Matteo Lambertini, Eva Blondeaux, Loredana Tomasello, Luca Boni, Judith Balmaña et al.
More posts featuring Armando Orlandi.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023